Overview of the different KOL roles across the lifecycle of a product

As a product moves from development to loss of exclusivity, the Key Opinion Leaders worth investing time in change with it. This one-page overview maps which KOL roles to prioritise at each stage, so your engagement plan evolves with the product instead of staying fixed on the same names.
 

Why your KOL priorities should shift across the product lifecycle


A Key Opinion Leader is an expert whose opinion carries weight with the prescribers, peers or payers a product is trying to reach. Which experts fit that description is not fixed. Critical success factors such as medical education, insights gathering, internal reimbursement support and data generation all carry different weight at each stage of the lifecycle, and so does the KOL role best placed to support them.

The role of the KOL throughout the lifecycle

Download the overview below 👇

The five stages covered are R&D, introduction, growth, maturity and generic competition.

  1. R&D: building disease awareness and clinical insight ahead of launch.
  2. Introduction: establishing product awareness through scientific, data-literate KOLs.
  3. Growth: broadening reach through regional KOLs with product experience.
  4. Maturity: widening the network to sustain awareness and patient care.
  5. Generic competition: maximising patient care across the full KOL and HCP network.
     

What you'll find in the overview


The download is a single, practical reference sheet. It focuses specifically on how your engagement priorities should change stage by stage.

  • The KOL role suited to each of four critical success factors: medical topics, insights gathering, internal support and data generation
  • How that role shifts across five stages, from R&D through to generic competition
  • Where the generalisation may not hold, and what to adjust for based on therapeutic area, company maturity and market
     

Download the overview

The role of the KOL throughout the lifecycle
I accept that relevant personal details are stored in a database for that purpose, as per our Privacy Policy, of which I accept the terms. *

Continue your learning from Maaike

If you’d like to learn more from Maaike, CELforPharma also offers a 1-day, hands-on course where you'll learn how to:

  • Identify, prioritise, and map the right type of KOLs for your medical objectives
  • Build engagement plans that evolve with your product’s lifecycle
  • Create mutually valuable, trust-based partnerships with experts
  • Strengthen the quality, structure, and internal alignment of your KOL activities
Strategic KOL Planning & Engagement
With Maaike Addicks, MD
Maaike Addicks, MD

Don’t miss the latest insights from our expert faculty

Subscribe to our newsletter to:

  • Stay on top of the latest expert insights
  • Receive invitations to upcoming educational webinars
  • Get updates on our courses and training programmes